首页> European journal of cancer (Oxford, England : 1990)> Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： S,Cavalieri

第一单位： Fondazione IRCCS Istituto Nazionale Dei Tumori, Medical Oncology/Head and Neck Unit, Milan, Italy.

作者： S,Cavalieri ^[1] ; F,Perrone ^[2] ; R,Miceli ^[3] ; P A,Ascierto ^[4] ; L D,Locati ^[1] ; C,Bergamini ^[1] ; R,Granata ^[1] ; S,Alfieri ^[1] ; C,Resteghini ^[1] ; D,Galbiati ^[1] ; A,Busico ^[2] ; N,Paielli ^[2] ; R,Patuzzo ^[5] ; A,Maurichi ^[5] ; G,Gallino ^[5] ; R,Ruggeri ^[5] ; L,Mariani ^[3] ; M,Palla ^[4] ; L,Licitra ^[6] ; P,Bossi ^[7]

作者单位： Fondazione IRCCS Istituto Nazionale Dei Tumori, Medical Oncology/Head and Neck Unit, Milan, Italy. ^[1] Fondazione IRCCS Istituto Nazionale Dei Tumori, Department of Pathology, Unit of Experimental Molecular Pathology, Milan, Italy. ^[2] Fondazione IRCCS Istituto Nazionale Dei Tumori, Clinical Epidemiology and Trial Organization, Milan, Italy. ^[3] Istituto Nazionale Tumori Fondazione "G. Pascale", Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Naples, Italy. ^[4] Fondazione IRCCS Istituto Nazionale Dei Tumori, Melanoma and Sarcoma Surgery Unit, Milan, Italy. ^[5] Fondazione IRCCS Istituto Nazionale Dei Tumori, Medical Oncology/Head and Neck Unit, Milan, Italy; Università Degli Studi di Milano, Medical Oncology Department, Milan, Italy. ^[6] Fondazione IRCCS Istituto Nazionale Dei Tumori, Medical Oncology/Head and Neck Unit, Milan, Italy. Electronic address: paolo.bossi@istitutotumori.mi.it. ^[7]

关键词 Dacomitinib Skin cancer Skin squamous cell carcinoma